Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Drugs For The Treatment Of Respiratory Diseases
Download Drugs For The Treatment Of Respiratory Diseases full books in PDF, epub, and Kindle. Read online Drugs For The Treatment Of Respiratory Diseases ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Drugs for the Treatment of Respiratory Diseases by : Domenico Spina
Download or read book Drugs for the Treatment of Respiratory Diseases written by Domenico Spina and published by Cambridge University Press. This book was released on 2003-01-30 with total page 622 pages. Available in PDF, EPUB and Kindle. Book excerpt: Respiratory diseases affect millions of people each year and represent a major health burden around the world. This timely reference surveys and evaluates the drug treatments available for the main categories of lung diseases including asthma, tuberculosis, chronic obstructive pulmonary disease, lung cancer, and respiratory infections. The recent re-emergence of tuberculosis and the increase in asthma in certain populations underlines the importance of finding effective new treatments for these diseases. This publication, a comprehensive reference, is one of the first to survey current and novel drug treatments for this group of diseases. It is certain to establish itself as an essential source of reference for respiratory physicians, clinicians and clinical pharmacologists.
Book Synopsis Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems by : Kamal Dua
Download or read book Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems written by Kamal Dua and published by Academic Press. This book was released on 2020-08-04 with total page 620 pages. Available in PDF, EPUB and Kindle. Book excerpt: Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulmonary disease management, looking down to the nanoscale level for an efficient system of targeting and managing respiratory disease. The book examines numerous nanoparticle-based drug systems such as nanocrystals, dendrimers, polymeric micelles, protein-based, carbon nanotube, and liposomes that can offer advantages over traditional drug delivery systems. Starting with a brief introduction on different types of nanoparticles in respiratory disease conditions, the book then focuses on current trends in disease pathology that use different in vitro and in vivo models. The comprehensive resource is designed for those new to the field and to specialized scientists and researchers involved in pulmonary research and drug development. Explores recent perspectives and challenges regarding the management and diagnosis of chronic respiratory diseases Provides insights into how advanced drug delivery systems can be effectively formulated and delivered for the management of various pulmonary diseases Includes the most recent information on diagnostic methods and treatment strategies using controlled drug delivery systems (including nanotechnology)
Book Synopsis Disease Control Priorities in Developing Countries by : Dean T. Jamison
Download or read book Disease Control Priorities in Developing Countries written by Dean T. Jamison and published by World Bank Publications. This book was released on 2006-04-02 with total page 1449 pages. Available in PDF, EPUB and Kindle. Book excerpt: Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.
Book Synopsis Oxford Desk Reference: Critical Care by : Carl Waldmann
Download or read book Oxford Desk Reference: Critical Care written by Carl Waldmann and published by Oxford University Press, USA. This book was released on 2008-11-27 with total page 629 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Oxford Desk Reference: Critical Care allows easy access to evidence-based materials on commonly encountered critical care problems for quick consultation to ensure the optimum management of a particular condition. A concise reference book, it collates key recommendations and presents them in an easily accessible and uniform way.
Book Synopsis Disease Control Priorities, Third Edition (Volume 5) by : Dorairaj Prabhakaran
Download or read book Disease Control Priorities, Third Edition (Volume 5) written by Dorairaj Prabhakaran and published by World Bank Publications. This book was released on 2017-11-17 with total page 948 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
Book Synopsis Evidence-Based Respiratory Medicine by : Peter G. Gibson
Download or read book Evidence-Based Respiratory Medicine written by Peter G. Gibson and published by John Wiley & Sons. This book was released on 2008-04-15 with total page 608 pages. Available in PDF, EPUB and Kindle. Book excerpt: First major evidence-based text in adult respiratory medicine Comprehensive, authoritative summary of the best treatments for the major respiratory diseases Compiled by specialists from the Cochrane Airways Management Group Easy-to-use format, with key clinical implications summarised in each chapter Kept up-to-date online Compiled by specialists from the Cochrane Collaboration Airways Management Group, Evidence-based Respiratory Medicine is the first major evidence-based text in adult respiratory medicine. Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world's leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter. Evidence-based Respiratory Medicine tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient's needs. Evidence-Based Series: Evidence-based Respiratory Medicine, part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text. Note: CD-ROM/DVD and other supplementary materials are not included as part of eBook file.
Book Synopsis Disease & Drug Consult: Respiratory Disorders by : Lippincott
Download or read book Disease & Drug Consult: Respiratory Disorders written by Lippincott and published by Lippincott Williams & Wilkins. This book was released on 2012-03-28 with total page 710 pages. Available in PDF, EPUB and Kindle. Book excerpt: Disease & Drug Consult is a unique new series of handbooks that combine disease monographs plus monographs on drugs used to treat diseases. Each Disease & Drug Consult book focuses on a specific body system and has two sections. Part 1 presents diseases alphabetically, with a description, causes & incidence, signs & symptoms, complications, diagnosis, treatment including drugs used to treat the disease and the reason for using each drug, and special considerations. Part 2, also organized alphabetically, offers complete drug monographs for each drug mentioned in the disease section. In the Respiratory Disorders volume, for example, the nurse can read a full description of asthma, then turn to the drug monographs for a full discussion of each of the drugs used to treat that disease.
Book Synopsis Rau's Respiratory Care Pharmacology E-Book by : Douglas S. Gardenhire
Download or read book Rau's Respiratory Care Pharmacology E-Book written by Douglas S. Gardenhire and published by Elsevier Health Sciences. This book was released on 2023-05-12 with total page 467 pages. Available in PDF, EPUB and Kindle. Book excerpt: You can breathe a little easier knowing there’s a proven way to master respiratory pharmacology! For more than 30 years, Rau’s Respiratory Care Pharmacology has been the preeminent text on the subject. With easy-to-grasp terminology, relatable explanations, and reader-friendly writing, it simplifies the process of learning pharmacology material like never before. Rau’s is organized into three logical sections, covering the basics of respiratory care, frequently used drugs, and critical care medications. New to the 11th edition are recently approved FDA drugs, information on drug approvals, COVID-19 coverage, and new and updated Clinical Connection boxes that focus on important clinical questions, assisting you in connecting the information in the text to the clinical setting and addressing how Respiratory Therapists can help educate patients. Clinical scenarios with follow-up SOAP assessment help you assess your comprehension of the material. Self-assessment questions offer you thought-provoking opportunities to test your comprehension of key concepts. Learning objectives parallel the levels tested by the NBRC® exams to help you identify important information that goes beyond memorization and recall. Key terms with definitions provide easy access to the pharmacologic vocabulary you should embrace. Key points boxes in each chapter highlight important concepts in the lesson. Glossary of all key terms in the text aids you in understanding the terminology associated with respiratory care pharmacology. Appendices on common Units and Systems of Measurement and Acceptable Mixtures provide references to need-to-know information such as abbreviations, conversion charts for temperatures, liquid metric and solids, and a simple drug compatibility chart for drug mixtures. Alphabetical drug index provides a direct index to look up information based on drug name. NEW and UPDATED! Clinical Connection boxes assist you in connecting information in the text to the clinical setting, including providing patients a better understanding of their clinical conditions as related to their drug treatments. UPDATED! Chapter 1 reflects changes to drug approval. UPDATED! Chapter 3 reflects changes in aerosol medication devices and addresses aerosol-generating device issues and COVID-19. UPDATED! The latest FDA-approved medications are referenced in all chapters. UPDATED! Current asthma (GINA) and COPD (GOLD) guidelines include COVID-19 treatment protocols. Enhanced readability helps you more easily understand difficult material.
Book Synopsis Anti-infectives and the Lung by : Stefano Aliberti
Download or read book Anti-infectives and the Lung written by Stefano Aliberti and published by European Respiratory Society. This book was released on 2017-03-01 with total page 332 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Advances in Pulmonary Drug Delivery by : Philip Chi Lip Kwok
Download or read book Advances in Pulmonary Drug Delivery written by Philip Chi Lip Kwok and published by CRC Press. This book was released on 2016-12-19 with total page 201 pages. Available in PDF, EPUB and Kindle. Book excerpt: The respiratory tract has been used to deliver biologically active chemicals into the human body for centuries. However, the lungs are complex in their anatomy and physiology, which poses challenges to drug delivery. Inhaled formulations are generally more sophisticated than those for oral and parenteral administration. Pulmonary drug development is therefore a highly specialized area because of its many unique issues and challenges. Rapid progress is being made and offers novel solutions to existing treatment problems. Advances in Pulmonary Drug Delivery highlights the latest developments in this field.
Book Synopsis Drug Treatment of Respiratory Disease by : Robert B. Cole
Download or read book Drug Treatment of Respiratory Disease written by Robert B. Cole and published by . This book was released on 1981 with total page 364 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Handbook of Lung Targeted Drug Delivery Systems by : Yashwant Pathak
Download or read book Handbook of Lung Targeted Drug Delivery Systems written by Yashwant Pathak and published by CRC Press. This book was released on 2021-10-17 with total page 692 pages. Available in PDF, EPUB and Kindle. Book excerpt: Handbook of Lung Targeted Drug Delivery Systems: Recent Trends and Clinical Evidences covers every aspect of the drug delivery to lungs, the physiology and pharmacology of the lung, modelling for lung delivery, drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applications. With the advent of nano sciences and significant development in the nano particulate drug delivery systems there has been a renewed interest in the lung as an absorption surface for various drugs. The emergence of the COVID-19 virus has brought lung and lung delivery systems into focus, this book covers new developments and research used to address the prevention and treatment of respiratory diseases. Written by well-known scientists with years of experience in the field this timely handbook is an excellent reference book for the scientists and industry professionals. Key Features: Focuses particularly on the chemistry, clinical pharmacology, and biological developments in this field of research. Presents comprehensive information on emerging nanotechnology applications in diagnosing and treating pulmonary diseases Explores drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applications Examines specific formulations targeted to pulmonary systems
Book Synopsis Drug Delivery to the Lung by : Hans Bisgaard
Download or read book Drug Delivery to the Lung written by Hans Bisgaard and published by CRC Press. This book was released on 2001-10-02 with total page 536 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book focuses on the aerosol treatment of lung diseases, recent improvements in the understanding of proper dosage, and major innovations in device technology applied to clinical practice. Examines the behavior of inspired spherical particles in the respiratory tract!Featuring over 1300 references, drawings, tables, and photographs.
Book Synopsis A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases by : Institute of Medicine
Download or read book A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases written by Institute of Medicine and published by National Academies Press. This book was released on 2011-08-26 with total page 200 pages. Available in PDF, EPUB and Kindle. Book excerpt: Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.
Book Synopsis Drug-Induced Lung Injury by : Masayuki Hanaoka
Download or read book Drug-Induced Lung Injury written by Masayuki Hanaoka and published by Springer. This book was released on 2017-10-18 with total page 214 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
Book Synopsis Respiratory Disease by : Anne E. Tattersfield
Download or read book Respiratory Disease written by Anne E. Tattersfield and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 271 pages. Available in PDF, EPUB and Kindle. Book excerpt: Respiratory Disease, the latest volume in the "Treatment in Clinical Medicine" series, is in two parts: the first reviews the background to each of the main respiratory diseases with particular emphasis on management and treatment. The second reviews the main drugs used in respiratory practice in more detail and combines a pharmacological appraisal with a more personal assessment of their role and value in treatment. Practical aspects of management are emphasised. Where uncertainty exists the authors have described their own practice. The book aims to fill the gap which exists between textbooks of respiratory medicine, where there is often insufficient space to cover treatment in detail, and pharmacological textbooks, which are not concerned with practical management problems. It is intended for respiratory physicians, general physicians and senior medical students, and will provide useful background information for researchers entering the the field.
Book Synopsis Pulmonary Rehabilitation by : Claudio Donner
Download or read book Pulmonary Rehabilitation written by Claudio Donner and published by CRC Press. This book was released on 2020-07-14 with total page 526 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pulmonary rehabilitation programmes are a fundamental part of the clinical management of patients with chronic respiratory diseases. This comprehensive reference book places pulmonary rehabilitation within the wider framework of respiratory disease. Now in six parts, it includes new sections on the development of PR as a discipline, global perspectives on quality control, new chapters on early PR post exacerbation and personalized rehabilitation, innovative approaches to exercise, PR in interstitial lung disease and lung transplantation, and the latest research into the application of music, dance and yoga. Key Features Global contributions compare practice around the world where differences have developed. New six Part structure covers new approaches to exercise testing, interstitial lung diseases and other diseases, and add-on interventions drawing on new technologies. Contains recommendations of the large collaborative ERS/ATS task forces on guidelines for PR as well as suggested policies for its implementation and use. Covers the important topic of balance impairment as a focus of rehabilitation for the at-risk patient and a new chapter on monitoring physical activity. The voices of patients and caregivers describe the impact of chronic respiratory disease on their lives. Features an exclusive chapter on COVID-19 that discusses the short- and long-term pathophysiological consequences, provides information about the potential role of physiotherapy in the management of hospitalized patients with confirmed or suspected COVID-19, and details on who, where, and how to deliver programs to COVID-19 and non COVID-19 patients in the lockdown and post lockdown era.
